Variant report
Variant | nsv609982 |
---|---|
Chromosome Location | chr8:5923666-5950104 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:5933019..5935981-chr8:5937353..5939270,2 | K562 | blood: | |
2 | chr8:5797855..5798416-chr8:5934095..5934883,2 | MCF-7 | breast: | |
3 | chr8:5933019..5936001-chr8:5936013..5938853,2 | K562 | blood: | |
4 | chr8:5933019..5936001-chr8:5936013..5938853,2 | K562 | blood: | |
5 | chr8:5933019..5935981-chr8:5937353..5939270,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4279617 | chr8:5923666-5923667 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs528859011 | chr8:5923687-5923688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs180834538 | chr8:5923714-5923715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2897871 | chr8:5923715-5923716 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs184131807 | chr8:5923757-5923758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189461909 | chr8:5923766-5923767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181169377 | chr8:5923780-5923781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186616063 | chr8:5923801-5923802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142909988 | chr8:5923818-5923819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190430517 | chr8:5923825-5923826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562233958 | chr8:5923827-5923828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531830450 | chr8:5923846-5923847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77460248 | chr8:5923865-5923866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571772760 | chr8:5923866-5923867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181629566 | chr8:5923880-5923881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73510256 | chr8:5923901-5923902 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs537323043 | chr8:5923917-5923918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186242546 | chr8:5923930-5923931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576074566 | chr8:5923950-5923951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372438008 | chr8:5923962-5923963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7842817 | chr8:5923975-5923976 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs555447286 | chr8:5923993-5923994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572161412 | chr8:5924061-5924062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369419662 | chr8:5924071-5924072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569946143 | chr8:5924082-5924083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370660595 | chr8:5924088-5924089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541155858 | chr8:5924089-5924090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145836239 | chr8:5924105-5924106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10676972 | chr8:5924126-5924127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534795145 | chr8:5924131-5924132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548041451 | chr8:5924132-5924133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564102043 | chr8:5924142-5924143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75567775 | chr8:5924156-5924157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190736087 | chr8:5924158-5924159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114356575 | chr8:5924164-5924165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563249740 | chr8:5924183-5924184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529205800 | chr8:5924209-5924210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138985904 | chr8:5924267-5924268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141461690 | chr8:5924275-5924276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528564897 | chr8:5924313-5924314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551879457 | chr8:5924314-5924315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372083956 | chr8:5924327-5924328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4875218 | chr8:5924333-5924334 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs56028045 | chr8:5924381-5924382 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs115485528 | chr8:5924390-5924391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184062517 | chr8:5924398-5924399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150858037 | chr8:5924402-5924403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185847734 | chr8:5924413-5924414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191095299 | chr8:5924426-5924427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534389008 | chr8:5924445-5924446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5923200-5925200 | Enhancers | Fetal Brain Male | brain |
2 | chr8:5923600-5923800 | Enhancers | Brain Inferior Temporal Lobe | brain |
3 | chr8:5923600-5924000 | Enhancers | Fetal Brain Female | brain |
4 | chr8:5929800-5930800 | Enhancers | Fetal Heart | heart |
5 | chr8:5930800-5934200 | Weak transcription | Fetal Heart | heart |
6 | chr8:5931400-5932600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr8:5932000-5932400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
8 | chr8:5932000-5932400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr8:5932600-5935800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr8:5934000-5934200 | Active TSS | Brain Hippocampus Middle | brain |
11 | chr8:5934200-5934400 | Flanking Active TSS | Brain Hippocampus Middle | brain |
12 | chr8:5934200-5934600 | Enhancers | Brain Anterior Caudate | brain |
13 | chr8:5934200-5934800 | Enhancers | Fetal Heart | heart |
14 | chr8:5934400-5934600 | Enhancers | Adipose Nuclei | Adipose |
15 | chr8:5934400-5934800 | Enhancers | Fetal Brain Male | brain |
16 | chr8:5935800-5936800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr8:5936200-5936600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr8:5942800-5943200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr8:5949000-5949800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |